CUSIP: 163572209
Q2 2015 13F Holders as of 30 Jun 2015
-
Type / Class
-
Equity / COM NEW
-
Total 13F shares
-
1,843,790
-
Share change
-
-50,518
-
Total reported value
-
$9,053,275
-
Price per share
-
$4.91
-
Number of holders
-
22
-
Value change
-
-$244,675
-
Number of buys
-
8
-
Number of sells
-
5
Quarterly Holders Quick Answers
What is CUSIP 163572209?
CUSIP 163572209 identifies CEMI - CHEMBIO DIAGNOSTICS INC - COM NEW in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
-
Newer quarter:
Q3 2015
-
Previous quarter:
Q1 2015
Recent filing periods for CUSIP 163572209:
Institutional Holders of CHEMBIO DIAGNOSTICS INC - COM NEW (CEMI) as of Q2 2015
As of 30 Jun 2015,
CHEMBIO DIAGNOSTICS INC - COM NEW (CEMI) was held by
22 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
1,843,790 shares.
The largest 10 holders included
WELLINGTON MANAGEMENT GROUP LLP, Stanley-Laman Group, Ltd., VANGUARD GROUP INC, Longwood Capital Partners LLC, BRIDGEWAY CAPITAL MANAGEMENT INC, Moors & Cabot, Inc., DAFNA Capital Management LLC, GRT CAPITAL PARTNERS L.L.C., Phocas Financial Corp., and GEODE CAPITAL MANAGEMENT, LLC.
This page lists
22
institutional shareholders reporting positions in this security
for the Q2 2015 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.